1. Home
  2. SCPH vs GGR Comparison

SCPH vs GGR Comparison

Compare SCPH & GGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • GGR
  • Stock Information
  • Founded
  • SCPH 2013
  • GGR 2011
  • Country
  • SCPH United States
  • GGR Taiwan
  • Employees
  • SCPH N/A
  • GGR N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • GGR Auto Manufacturing
  • Sector
  • SCPH Health Care
  • GGR Consumer Discretionary
  • Exchange
  • SCPH Nasdaq
  • GGR Nasdaq
  • Market Cap
  • SCPH 160.6M
  • GGR 166.7M
  • IPO Year
  • SCPH 2017
  • GGR N/A
  • Fundamental
  • Price
  • SCPH $3.28
  • GGR $0.43
  • Analyst Decision
  • SCPH Strong Buy
  • GGR Hold
  • Analyst Count
  • SCPH 2
  • GGR 2
  • Target Price
  • SCPH $15.00
  • GGR $0.50
  • AVG Volume (30 Days)
  • SCPH 251.3K
  • GGR 328.9K
  • Earning Date
  • SCPH 03-12-2025
  • GGR 02-13-2025
  • Dividend Yield
  • SCPH N/A
  • GGR N/A
  • EPS Growth
  • SCPH N/A
  • GGR N/A
  • EPS
  • SCPH N/A
  • GGR N/A
  • Revenue
  • SCPH $30,278,000.00
  • GGR $329,041,000.00
  • Revenue This Year
  • SCPH $173.14
  • GGR N/A
  • Revenue Next Year
  • SCPH $131.01
  • GGR $3.73
  • P/E Ratio
  • SCPH N/A
  • GGR N/A
  • Revenue Growth
  • SCPH 303.87
  • GGR N/A
  • 52 Week Low
  • SCPH $3.08
  • GGR $0.40
  • 52 Week High
  • SCPH $6.54
  • GGR $2.24
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 41.79
  • GGR 29.97
  • Support Level
  • SCPH $3.15
  • GGR $0.41
  • Resistance Level
  • SCPH $3.52
  • GGR $0.43
  • Average True Range (ATR)
  • SCPH 0.18
  • GGR 0.02
  • MACD
  • SCPH -0.00
  • GGR -0.00
  • Stochastic Oscillator
  • SCPH 15.22
  • GGR 12.63

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

About GGR Gogoro Inc.

Gogoro Inc is focused on eliminating the barriers to electric fuel adoption to bring swappable electric power within reach of every urban rider. Its battery swapping technology compromises an interoperable platform that seamlessly integrates a comprehensive ecosystem of hardware, software, and services, which consists of Gogoro Smart Batteries, GoStations, Gogoro Network Software & Battery Management Systems, Smartscooter, and related components and kits. Geographical presence in Taiwan and Other countries, majority of its revenue comes from Tiwan.

Share on Social Networks: